Comments on the Eslicarbazepine Acetate Section of the Article ‘Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications’.docVIP

Pharmaceuticals 2010, 3, 3629-3632; doi:10.3390/ph3123629 OPEN ACCESS pharmaceuticals ISSN 1424-8247 /journal/pharmaceuticals Commentary Comments on the Eslicarbazepine Acetate Section of the Article ‘Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications’ Ahmet H. ?ztiryaki * and Patricio Soares-da-Silva BIAL - Portela Ca, S.A., S. Mamede do Coronado, Portugal * Author to whom correspondence should be addressed; E-Mail: haluk.oztiryaki@ (A.H.?.); Tel.: +351-22-9866100; Fax: +351-22-9866192. Received: 9 November 2010 / Accepted: 16 December 2010 / Published: 17 December 2010 A